US Stock MarketDetailed Quotes

Jaguar Health (JAGX)

Watchlist
  • 3.270
  • -0.280-7.89%
Close Jun 1 16:00 ET
  • 3.230
  • -0.040-1.22%
Post 20:01 ET
2.15MMarket Cap-0.02P/E (TTM)

Jaguar Health (JAGX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
814.50%20.25M
-1.52%11.51M
-7.81%3.24M
-0.80%3.08M
9.48%2.98M
-5.83%2.21M
19.75%11.69M
52.57%3.51M
10.49%3.11M
1.68%2.72M
Operating revenue
530.35%20.34M
-0.56%15.5M
-5.80%4.25M
1.22%4.07M
8.80%3.95M
-5.64%3.23M
14.53%15.58M
25.10%4.52M
8.94%4.02M
4.77%3.63M
Cost of revenue
124.85%1.16M
93.04%3.77M
294.97%2.2M
-1.66%532K
23.42%527K
19.77%515K
-4.03%1.96M
-18.92%557K
5.25%541K
-13.03%427K
Gross profit
1,023.54%19.09M
-20.52%7.74M
-64.94%1.04M
-0.62%2.55M
6.89%2.45M
-11.56%1.7M
26.02%9.73M
83.01%2.95M
11.66%2.57M
4.99%2.29M
Operating expense
-19.90%8.91M
30.27%52.85M
93.33%21.48M
-0.41%9.79M
10.20%10.46M
9.71%11.12M
-2.59%40.57M
26.25%11.11M
-11.34%9.83M
-7.74%9.49M
Selling and administrative expenses
-34.32%4.54M
17.30%26.02M
12.06%5.31M
5.96%6.13M
23.23%7.19M
18.66%6.91M
-3.75%22.18M
-11.26%4.74M
15.60%5.79M
-2.86%5.84M
-Selling and marketing expense
-75.08%232K
1.83%4.17M
-23.31%1.47M
-11.95%737K
46.46%1.03M
40.85%931K
24.70%4.09M
131.60%1.91M
31.40%837K
-19.59%706K
-General and administrative expense
-27.98%4.31M
20.80%21.85M
36.04%3.84M
8.99%5.39M
20.03%6.16M
15.82%5.98M
-8.48%18.09M
-37.43%2.82M
13.30%4.95M
0.00%5.13M
Research and development costs
5.31%3.93M
50.92%24.97M
215.68%14.31M
-9.52%3.66M
-10.62%3.27M
-13.50%3.73M
-11.05%16.54M
30.93%4.53M
-33.51%4.04M
-14.59%3.65M
Depreciation amortization depletion
-2.92%465K
0.98%1.86M
----
----
----
--479K
--1.84M
----
----
----
-Depreciation and amortization
-2.92%465K
0.98%1.86M
----
----
----
--479K
--1.84M
----
----
----
Other operating expenses
---25K
----
----
----
----
----
----
----
----
----
Operating profit
208.08%10.18M
-46.31%-45.11M
-150.61%-20.44M
0.33%-7.24M
-11.25%-8.01M
-14.68%-9.42M
9.11%-30.83M
-13.51%-8.16M
17.36%-7.26M
11.17%-7.2M
Net non-operating interest income expense
-1,348.21%-699K
71.00%-67K
-220.00%-132K
-103.70%-6K
-86.11%15K
109.17%56K
96.38%-231K
144.35%110K
132.40%162K
103.13%108K
Non-operating interest income
----
----
----
----
----
--56K
----
----
----
----
Non-operating interest expense
--699K
-71.00%67K
----
----
----
----
-96.38%231K
----
----
----
Total other finance cost
----
----
----
103.70%6K
86.11%-15K
----
----
----
-132.40%-162K
-103.13%-108K
Other net income (expense)
38.26%-760K
-7.73%-8.82M
-19.75%-2.62M
17.70%-2.4M
-1.14%-2.57M
-127.12%-1.23M
-412.13%-8.19M
-16.64%-2.19M
-311.21%-2.92M
-244.97%-2.54M
Gain on sale of security
74.91%-337K
33.94%-6.27M
39.77%-1.55M
25.22%-2.31M
40.99%-1.07M
33.55%-1.34M
-85.07%-9.49M
-45.74%-2.57M
-37.66%-3.09M
-137.53%-1.81M
Special income (charges)
---628K
-308.76%-2.6M
---777K
--0
---1.82M
--0
-62.57%1.25M
--0
--0
--0
-Less:Impairment of capital assets
----
--800K
----
----
----
----
--0
----
----
----
-Less:Other special charges
--628K
244.50%1.8M
---23K
----
--1.82M
----
66.32%-1.25M
--0
----
----
Other non- operating income (expenses)
83.04%205K
-15.69%43K
-178.57%-297K
-155.95%-94K
144.17%322K
-52.14%112K
-74.50%51K
47.66%378K
340.00%168K
-2,903.85%-729K
Income before tax
182.32%8.72M
-37.57%-54M
-126.63%-23.19M
3.72%-9.65M
-9.68%-10.56M
-13.11%-10.6M
6.32%-39.25M
-9.94%-10.23M
-26.78%-10.02M
21.67%-9.63M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
182.32%8.72M
-37.57%-54M
-126.63%-23.19M
3.72%-9.65M
-9.68%-10.56M
-13.11%-10.6M
6.32%-39.25M
-9.94%-10.23M
-26.78%-10.02M
21.67%-9.63M
Net income continuous Operations
182.32%8.72M
-37.57%-54M
-126.63%-23.19M
3.72%-9.65M
-9.68%-10.56M
-13.11%-10.6M
6.32%-39.25M
-9.94%-10.23M
-26.78%-10.02M
21.67%-9.63M
Minority interest income
4.55%-126K
25.82%-563K
57.96%-132K
12.57%-146K
-12.50%-153K
7.04%-132K
-26.29%-759K
-125.90%-314K
-32.54%-167K
3.55%-136K
Net income attributable to the parent company
184.57%8.85M
-38.82%-53.43M
-132.47%-23.06M
3.57%-9.5M
-9.64%-10.41M
-13.42%-10.46M
6.80%-38.49M
-8.18%-9.92M
-26.69%-9.85M
21.88%-9.49M
Preferred stock dividends
15.86M
141K
Other preferred stock dividends
Net income attributable to common stockholders
32.96%-7.02M
-39.18%-53.58M
-133.89%-23.2M
3.57%-9.5M
-9.64%-10.41M
-13.42%-10.46M
6.80%-38.49M
-8.18%-9.92M
-26.69%-9.85M
21.88%-9.49M
Basic earnings per share
18.56%-476
82.42%-803.95
82.28%-116.4005
76.11%-219.8
84.57%-359.1
80.83%-584.45
84.52%-4.57K
89.98%-657.0407
94.42%-920.15
93.03%-2.33K
Diluted earnings per share
18.56%-476
82.42%-803.95
82.28%-116.4005
76.11%-219.8
84.57%-359.1
80.83%-584.45
84.52%-4.57K
89.98%-657.0407
94.42%-920.15
93.03%-2.33K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 814.50%20.25M-1.52%11.51M-7.81%3.24M-0.80%3.08M9.48%2.98M-5.83%2.21M19.75%11.69M52.57%3.51M10.49%3.11M1.68%2.72M
Operating revenue 530.35%20.34M-0.56%15.5M-5.80%4.25M1.22%4.07M8.80%3.95M-5.64%3.23M14.53%15.58M25.10%4.52M8.94%4.02M4.77%3.63M
Cost of revenue 124.85%1.16M93.04%3.77M294.97%2.2M-1.66%532K23.42%527K19.77%515K-4.03%1.96M-18.92%557K5.25%541K-13.03%427K
Gross profit 1,023.54%19.09M-20.52%7.74M-64.94%1.04M-0.62%2.55M6.89%2.45M-11.56%1.7M26.02%9.73M83.01%2.95M11.66%2.57M4.99%2.29M
Operating expense -19.90%8.91M30.27%52.85M93.33%21.48M-0.41%9.79M10.20%10.46M9.71%11.12M-2.59%40.57M26.25%11.11M-11.34%9.83M-7.74%9.49M
Selling and administrative expenses -34.32%4.54M17.30%26.02M12.06%5.31M5.96%6.13M23.23%7.19M18.66%6.91M-3.75%22.18M-11.26%4.74M15.60%5.79M-2.86%5.84M
-Selling and marketing expense -75.08%232K1.83%4.17M-23.31%1.47M-11.95%737K46.46%1.03M40.85%931K24.70%4.09M131.60%1.91M31.40%837K-19.59%706K
-General and administrative expense -27.98%4.31M20.80%21.85M36.04%3.84M8.99%5.39M20.03%6.16M15.82%5.98M-8.48%18.09M-37.43%2.82M13.30%4.95M0.00%5.13M
Research and development costs 5.31%3.93M50.92%24.97M215.68%14.31M-9.52%3.66M-10.62%3.27M-13.50%3.73M-11.05%16.54M30.93%4.53M-33.51%4.04M-14.59%3.65M
Depreciation amortization depletion -2.92%465K0.98%1.86M--------------479K--1.84M------------
-Depreciation and amortization -2.92%465K0.98%1.86M--------------479K--1.84M------------
Other operating expenses ---25K------------------------------------
Operating profit 208.08%10.18M-46.31%-45.11M-150.61%-20.44M0.33%-7.24M-11.25%-8.01M-14.68%-9.42M9.11%-30.83M-13.51%-8.16M17.36%-7.26M11.17%-7.2M
Net non-operating interest income expense -1,348.21%-699K71.00%-67K-220.00%-132K-103.70%-6K-86.11%15K109.17%56K96.38%-231K144.35%110K132.40%162K103.13%108K
Non-operating interest income ----------------------56K----------------
Non-operating interest expense --699K-71.00%67K-----------------96.38%231K------------
Total other finance cost ------------103.70%6K86.11%-15K-------------132.40%-162K-103.13%-108K
Other net income (expense) 38.26%-760K-7.73%-8.82M-19.75%-2.62M17.70%-2.4M-1.14%-2.57M-127.12%-1.23M-412.13%-8.19M-16.64%-2.19M-311.21%-2.92M-244.97%-2.54M
Gain on sale of security 74.91%-337K33.94%-6.27M39.77%-1.55M25.22%-2.31M40.99%-1.07M33.55%-1.34M-85.07%-9.49M-45.74%-2.57M-37.66%-3.09M-137.53%-1.81M
Special income (charges) ---628K-308.76%-2.6M---777K--0---1.82M--0-62.57%1.25M--0--0--0
-Less:Impairment of capital assets ------800K------------------0------------
-Less:Other special charges --628K244.50%1.8M---23K------1.82M----66.32%-1.25M--0--------
Other non- operating income (expenses) 83.04%205K-15.69%43K-178.57%-297K-155.95%-94K144.17%322K-52.14%112K-74.50%51K47.66%378K340.00%168K-2,903.85%-729K
Income before tax 182.32%8.72M-37.57%-54M-126.63%-23.19M3.72%-9.65M-9.68%-10.56M-13.11%-10.6M6.32%-39.25M-9.94%-10.23M-26.78%-10.02M21.67%-9.63M
Income tax 0000000000
Net income 182.32%8.72M-37.57%-54M-126.63%-23.19M3.72%-9.65M-9.68%-10.56M-13.11%-10.6M6.32%-39.25M-9.94%-10.23M-26.78%-10.02M21.67%-9.63M
Net income continuous Operations 182.32%8.72M-37.57%-54M-126.63%-23.19M3.72%-9.65M-9.68%-10.56M-13.11%-10.6M6.32%-39.25M-9.94%-10.23M-26.78%-10.02M21.67%-9.63M
Minority interest income 4.55%-126K25.82%-563K57.96%-132K12.57%-146K-12.50%-153K7.04%-132K-26.29%-759K-125.90%-314K-32.54%-167K3.55%-136K
Net income attributable to the parent company 184.57%8.85M-38.82%-53.43M-132.47%-23.06M3.57%-9.5M-9.64%-10.41M-13.42%-10.46M6.80%-38.49M-8.18%-9.92M-26.69%-9.85M21.88%-9.49M
Preferred stock dividends 15.86M141K
Other preferred stock dividends
Net income attributable to common stockholders 32.96%-7.02M-39.18%-53.58M-133.89%-23.2M3.57%-9.5M-9.64%-10.41M-13.42%-10.46M6.80%-38.49M-8.18%-9.92M-26.69%-9.85M21.88%-9.49M
Basic earnings per share 18.56%-47682.42%-803.9582.28%-116.400576.11%-219.884.57%-359.180.83%-584.4584.52%-4.57K89.98%-657.040794.42%-920.1593.03%-2.33K
Diluted earnings per share 18.56%-47682.42%-803.9582.28%-116.400576.11%-219.884.57%-359.180.83%-584.4584.52%-4.57K89.98%-657.040794.42%-920.1593.03%-2.33K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 1, Eastern Time, the geopolitical situation in the Middle East took a dramatic turn. Iran's Tasnim News Agency reported that, in lig Show More